La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Kindstar Globalgene Technology Croissance future
Future contrôle des critères 5/6
Kindstar Globalgene Technology is forecast to grow earnings and revenue by 48.4% and 24.7% per annum respectively. EPS is expected to grow by 46% per annum. Return on equity is forecast to be 3.1% in 3 years.
Informations clés
48.4%
Taux de croissance des bénéfices
46.0%
Taux de croissance du BPA
Healthcare croissance des bénéfices | 15.6% |
Taux de croissance des recettes | 24.7% |
Rendement futur des capitaux propres | 3.1% |
Couverture par les analystes | Low |
Dernière mise à jour | 03 Jun 2024 |
Mises à jour récentes de la croissance future
Recent updates
We Think That There Are More Issues For Kindstar Globalgene Technology (HKG:9960) Than Just Sluggish Earnings
Apr 03Kindstar Globalgene Technology (HKG:9960) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Aug 22Analysts Just Made A Notable Upgrade To Their Kindstar Globalgene Technology, Inc. (HKG:9960) Forecasts
Aug 18We're Not Very Worried About Kindstar Globalgene Technology's (HKG:9960) Cash Burn Rate
Jul 07Kindstar Global (Beijing) Technology, Inc. (HKG:9960) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 28Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2025 | 1,611 | 133 | N/A | 734 | 1 |
12/31/2024 | 1,321 | 110 | N/A | 639 | 1 |
12/31/2023 | 967 | 41 | -188 | -15 | N/A |
9/30/2023 | 1,094 | 49 | -143 | 3 | N/A |
6/30/2023 | 1,220 | 57 | -98 | 22 | N/A |
3/31/2023 | 1,303 | 66 | -100 | 21 | N/A |
12/31/2022 | 1,387 | 75 | -103 | 21 | N/A |
9/30/2022 | 1,269 | 93 | -195 | 28 | N/A |
6/30/2022 | 1,152 | 110 | -287 | 34 | N/A |
3/31/2022 | 1,041 | -672 | -254 | 51 | N/A |
12/31/2021 | 931 | -1,454 | -220 | 68 | N/A |
9/30/2021 | 915 | -1,919 | -93 | 73 | N/A |
6/30/2021 | 900 | -2,384 | 34 | 78 | N/A |
3/31/2021 | 896 | -1,679 | 40 | 76 | N/A |
12/31/2020 | 891 | -974 | 47 | 73 | N/A |
12/31/2019 | 833 | -170 | 58 | 99 | N/A |
12/31/2018 | 706 | -53 | -7 | 54 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 9960's forecast earnings growth (48.4% per year) is above the savings rate (2.3%).
Bénéfices vs marché: 9960's earnings (48.4% per year) are forecast to grow faster than the Hong Kong market (11% per year).
Croissance élevée des bénéfices: 9960's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: 9960's revenue (24.7% per year) is forecast to grow faster than the Hong Kong market (7.4% per year).
Croissance élevée des revenus: 9960's revenue (24.7% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: 9960's Return on Equity is forecast to be low in 3 years time (3.1%).